e-learning
resources
Copenhagen 2005
Wednesday 21.09.2005
Resistant and multidrug resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Recent transmission of drug resistant
M. tuberculosis
in Latvia
A. Nodieva, I. Jansone, L. Broka, G. Skenders, T. Tracevska, V. Baumanis (Riga, Latvia)
Source:
Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Session:
Resistant and multidrug resistant tuberculosis
Session type:
Oral Presentation
Number:
4464
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Nodieva, I. Jansone, L. Broka, G. Skenders, T. Tracevska, V. Baumanis (Riga, Latvia). Recent transmission of drug resistant
M. tuberculosis
in Latvia. Eur Respir J 2005; 26: Suppl. 49, 4464
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Increasing incidence of fluoroquinolone resistant tuberculosis in Bombay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Molecular surveillance of multi-drug resistant tuberculosis in Europe
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Strategies against multidrug-resistant tuberculosis
Source: Eur Respir J 2002; 20: 66S-77S
Year: 2002
TB drug resistance in high-incidence countries
Source: Eur Respir Mon 2012; 58: 95-110
Year: 2012
Molecular epidemiology of M. tuberculosis drug resistance in Europe
Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Year: 2015
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Source: Eur Respir J 2012; 39: 1425-1431
Year: 2012
Risk factors for recent transmission of Mycobacterium tuberculosis
Source: Eur Respir J 2003 Oct 01;22(4):637-642
Year: 2003
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Source: Eur Respir J 2012; 39: 626-634
Year: 2012
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000
Source: Eur Respir J 2003; 21: 129-134
Year: 2003
The burden of childhood and adult tuberculosis, including MDR and TDR TB
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014
The prevalence of latent pulmonary tuberculosis infection (LTBI) in low and high risk populations in Ireland
Source: Eur Respir J 2005; 26: Suppl. 49, 425s
Year: 2005
Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Molecular epidemiology of multi drug resistance tuberculosis isolates from pulmonary tuberculosis cases from Lucknow, India
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006
A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995 2004
Source: Eur Respir J 2007; 30: 937-944
Year: 2007
The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine.
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018
Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel
Source: Eur Respir J 2008; 32: 413-418
Year: 2008
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept